MedUS Medical - Company finances
|
EUR
|
2023
From: 2023-02-21
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|
|
Financial data
|
|||
| Sales revenue | 8,505,389 | 11,249,971 | 16,966,803 |
| Profit before tax | 295,118 | 420,436 | 1,429,996 |
| Net profit | 288,527 | 352,922 | 1,253,620 |
| Equity | 1,407,129 | 1,720,051 | 2,873,671 |
| Liabilities | 2,528,670 | 2,788,949 | 4,801,309 |
| Non-current assets | 563,670 | 790,186 | 1,151,197 |
| Current assets | 3,604,416 | 3,678,044 | 6,486,933 |
| Total assets | 4,168,086 | 4,468,230 | 7,638,130 |
|
Taxes paid
|
|||
| STI taxes | 695,224 | 1,567,418 | 2,393,961 |
| Social insurance contributions | 193,873 | 307,437 | 403,647 |
|
Financial indicators
|
|||
| Revenue change y/y | - | +32.3% | +50.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 6.9% | 7.9% | 16.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 20.5% | 20.5% | 43.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 3.4% | 3.1% | 7.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 3.5% | 3.7% | 8.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.8 | 1.6 | 1.7 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 349,102 | 379,212 | 510,280 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
MedUS Medical - Social security debts
The company had no debts to Sodra
MedUS Medical - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-07-13 | 2026-07-26 | 3644.0 |
| 2025-03-26 | 2025-03-27 | 4.99 |
| 2025-02-20 | 2025-02-25 | 0.99 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
MedUS Medical, UAB (code 306252616) is a Private Limited Liability Company engaged in wholesale of pharmaceutical and medical goods. In 2025, the company generated EUR 16.97 million in revenue, an increase of 50.8% year on year and almost double the 2023 level. Net profit rose to EUR 1.25 million in 2025 from EUR 352.9 thousand in 2024 and EUR 288.5 thousand in 2023, while the profit margin improved to 7.4% from 3.1% and 3.4% in the previous two years. The three-year trend shows strong growth in both scale and profitability. Total assets increased to EUR 7.64 million in 2025 from EUR 4.47 million in 2024 and EUR 4.17 million in 2023. Equity strengthened to EUR 2.87 million, while liabilities reached EUR 4.80 million. The equity ratio stood at 37.6% and debt-to-equity at 1.67. Return on equity was 43.6% and return on assets 16.4%, supported by asset turnover of 2.22x. Revenue per employee reached EUR 514.1 thousand and profit per employee EUR 38.0 thousand.